Literature DB >> 1700808

Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.

M Vainzof1, R C Pavanello, I Pavanello Filho, M R Passos-Bueno, D Rapaport, C T Hsi, M Zatz.   

Abstract

The localization of the protein dystrophin was studied using the immunofluorescence method, in muscle biopsies from 74 patients affected by different types of muscular dystrophy and 4 normal controls. In 15 patients with limb-girdle muscular dystrophy (LGMD) the pattern was indistinguishable from normal. Among 42 Duchenne patients (DMD), 3 were totally negative and 39 showed a variable proportion (4-30%) of partially labelled fibers. With one exception 17 Becker dystrophy patients (BMD), showed a positive sarcolemmal reaction. A diffuse reaction inside the fibers, which was not observed in normal controls, was seen in the majority of DMD and also in some of the BMD patients. Based on these observations it is suggested that in DMD, a small quantity of protein is still present or there is a cross-reaction with other proteins which share some homology with dystrophin. The present results suggest that it is possible to make a differential diagnosis between DMD and BMD through dystrophin immunohistochemistry. However, to distinguish between patients with BMD and LGMD phenotypes, or DMD and outliers, complementary immunoblot studies and quantitative determination of dystrophin are necessary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700808     DOI: 10.1016/0022-510x(90)90263-m

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Genetic and clinical correlations of Xp21 muscular dystrophy.

Authors:  K M Bushby
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.

Authors:  M Vainzof; M R Passos-Bueno; R C Pavanello; R Schreiber; M Zatz
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

3.  Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families.

Authors:  M R Passos-Bueno; E S Moreira; S K Marie; R Bashir; L Vasquez; D R Love; M Vainzof; P Iughetti; J R Oliveira; E Bakker; T Strachan; K Bushby; M Zatz
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

4.  Evidence of genetic heterogeneity in the autosomal recessive adult forms of limb-girdle muscular dystrophy following linkage analysis with 15q probes in Brazilian families.

Authors:  M R Passos-Bueno; I Richard; M Vainzof; F Fougerousse; J Weissenbach; O Broux; D Cohen; J Akiyama; S K Marie; A A Carvalho
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

5.  Cosegregation of schizophrenia with Becker muscular dystrophy: susceptibility locus for schizophrenia at Xp21 or an effect of the dystrophin gene in the brain?

Authors:  M Zatz; H Vallada; M S Melo; M R Passos-Bueno; A H Vieira; M Vainzof; M Gill; V Gentil
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

6.  Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.

Authors:  Natassia M Vieira; Ingegerd Elvers; Matthew S Alexander; Yuri B Moreira; Alal Eran; Juliana P Gomes; Jamie L Marshall; Elinor K Karlsson; Sergio Verjovski-Almeida; Kerstin Lindblad-Toh; Louis M Kunkel; Mayana Zatz
Journal:  Cell       Date:  2015-11-12       Impact factor: 41.582

7.  Neuromuscular disorders: genes, genetic counseling and therapeutic trials.

Authors:  Mayana Zatz; Maria Rita Passos-Bueno; Mariz Vainzof
Journal:  Genet Mol Biol       Date:  2016 Jul-Sep       Impact factor: 1.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.